butantrone has been researched along with Psoriasis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, H; Mustakallio, KK | 1 |
| Göransson, AM; Kolari, PJ; Mustakallio, KK | 1 |
| Haasio, K; Männistö, PT; Viluksela, M | 1 |
| Greaves, MW | 1 |
| Brandt, H | 1 |
| Göransson, A | 2 |
| Remitz, A | 1 |
| Collan, Y; Hanhijärvi, H; Kosma, VM; Männistö, PT | 1 |
4 trial(s) available for butantrone and Psoriasis
| Article | Year |
|---|---|
Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
Topics: Anthracenes; Anthralin; Drug Evaluation; Humans; Psoriasis | 1984 |
Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis.
Topics: Adolescent; Adult; Anthralin; Clinical Trials as Topic; Drug Eruptions; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Staining and Labeling | 1986 |
Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
Topics: Administration, Topical; Adult; Anthralin; Clinical Trials as Topic; Female; Humans; Irritants; Male; Psoriasis; Skin Pigmentation | 1987 |
Comparison of dithranol and butantrone in short contact therapy of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Osmolar Concentration; Psoriasis; Time Factors | 1987 |
5 other study(ies) available for butantrone and Psoriasis
| Article | Year |
|---|---|
Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
Topics: Anthracenes; Anthralin; Drug Administration Schedule; Erythema; Humans; Psoriasis; Skin; Staining and Labeling; Time Factors | 1984 |
Studies on the contact sensitizing activity of dithranol (anthralin) and 10-butyryl dithranol (butantrone).
Topics: Animals; Anthralin; Dermatitis, Contact; Disease Models, Animal; Dose-Response Relationship, Immunologic; Female; Freund's Adjuvant; Guinea Pigs; Injections, Intradermal; Irritants; Mice; Mice, Inbred BALB C; Patch Tests; Psoriasis | 1990 |
Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
Topics: Anthralin; Dose-Response Relationship, Drug; Humans; Irritants; Psoriasis; Regional Blood Flow; Skin; Skin Pigmentation; Time Factors | 1987 |
Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
Topics: Adult; Aged; Anthralin; Female; Humans; Male; Middle Aged; Psoriasis; Time Factors | 1989 |
A 6-month dermal toxicity test with dithranol and butantrone in miniature swine.
Topics: Administration, Topical; Animals; Anthralin; Drug Eruptions; Drug Evaluation, Preclinical; Female; Gels; Hyperplasia; Male; Ointments; Psoriasis; Skin; Swine; Swine, Miniature; Time Factors | 1986 |